[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BridgeBio Pharma, Inc. Common Stock (BBIO)
BridgeBio Pharma (BBIO) hits a 1-year high driven by positive clinical data and potential M&A interest. Social media engagement and positive sentiment surge, with analysts reiterating a Buy rating and a high price target.
About BridgeBio Pharma, Inc. Common Stock
BridgeBio Pharma, Inc. Common Stock (BBIO) is a biotechnology company focused on developing and delivering medicines for genetic diseases and cancers.
BridgeBio Pharma, Inc. Common Stock uses the ticker $BBIO for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- BridgeBio Pharma, Inc. Common Stock (BBIO) trading volume is up XXXXXX% from the previous week.
- BridgeBio Pharma, Inc. Common Stock (BBIO) social dominance is up XXXXXX% from the previous week.
- BridgeBio Pharma, Inc. Common Stock (BBIO) galaxy score™ is up XXXXXX% from the previous X months.
- BridgeBio Pharma, Inc. Common Stock Price hit a 52-Week high of XX for the hour
- BridgeBio Pharma, Inc. Common Stock Price hit an all time of XX for the hour
Price: $XXXXX #
Price 24-Hour Time-Series Raw Data
The stock price is at a 1-year high, up XXXX% in the last XX hours, fueled by positive sentiment from clinical data, growth potential, and potential M&A activity, as many social posts suggest.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | XXXX% | XXXX% |
1-Year High: $XXXXX on 2025-10-14
1-Year Low: $XXXXX on 2024-11-18
AltRank: XXX #
AltRank 24-Hour Time-Series Raw Data
BridgeBio Pharma, Inc. Common Stock (BBIO) is currently AltRank #951 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +50
1 Month: XXX -XXX
6 Months: XXX -XXX
1 Year: XXX +545
1-Year High: XXXXX on 2025-09-25
1-Year Low: X on 2024-11-24
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +14
1 Month: XX +18
6 Months: XX +41
1 Year: XX +8
1-Year High: XX on 2025-02-04
1-Year Low: X on 2024-10-22
Engagements: XXXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX -XX%
1 Year: XXXXXXXXXX +119%
1-Year High: XXXXXXX on 2024-11-25
1-Year Low: XXXXX on 2025-09-27
| Social Network | X |
|---|---|
| Engagements | XXXXXX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX -XX%
1 Year: XXXXX +156%
1-Year High: XXX on 2024-11-25
1-Year Low: XX on 2025-10-15
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning BridgeBio Pharma, Inc. Common Stock (BBIO) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XXX
1 Month: XX -XX%
6 Months: XXXXX +60%
1 Year: XXXXX +218%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-10-15
The most influential creators that mention BridgeBio Pharma, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Quantumup1 | X | XXXXX | X | XXXXX |
| @GeneInvesting | X | XXXXXX | X | XXXXX |
| @MacroSkokie | X | XXXXX | X | XXX |
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @SteveDJacobs | X | XXXXX | X | XX |
| @semodough | X | XXXXXX | X | XX |
| @MarcJacksonLA | X | XXXXX | X | XX |
| @Biotech2k1 | X | XXXXXX | X | X |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XXX% +10%
6 Months: XXX% +42%
1 Year: XXX% +11%
1-Year High: XXX% on 2025-09-28
1-Year Low: XX% on 2025-05-28
Most Supportive Themes
- Positive Clinical Data: (36%) Positive clinical data, particularly regarding Acoramidis, are driving optimism among investors.
- Commercial Viability and Growth Potential: (31%) Analysts and investors express confidence in BridgeBio's commercial viability and potential for growth.
- Acquisition Potential and Industry Comparisons: (21%) Comparisons to other successful biotech companies and mentions of potential M&A activity suggest a positive outlook.
Most Critical Themes
- Competition and Market Challenges: (3%) Concerns about competition from established players in the market.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | X% | XXXXXX | XX% | X | X% |
| Total | XXX | X% | XXXXXX | XX% | X | X% |
Social Dominance: XXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.011%
1 Month: XXXXXXX% -XXXXXXXXXXXXXXXXXXXXX%
6 Months: XXXXXXX% -XXXXX%
1 Year: XXXXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-11-25
1-Year Low: XXXXXX% on 2025-09-28
Market Dominance: XXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-10-12
1-Year Low: XXXXXXX% on 2025-03-11
Market Cap: $XXXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX +$4.20%
1 Month: $XXXXXXXXXXXXXX +$10%
6 Months: $XXXXXXXXXXXXXX +$68%
1 Year: $XXXXXXXXXXXXXX +$123%
1-Year High: $XXXXXXXXXXXXXX on 2025-10-14
1-Year Low: $XXXXXXXXXXXXX on 2024-11-18
Top assets mentioned In the posts about BridgeBio Pharma, Inc. Common Stock in the last XX hours
Alnylam Pharmaceuticals, Inc. (ALNY) Intellia Therapeutics, Inc (NTLA) Pfizer, Inc. (PFE) Alnylam Pharmaceuticals, Inc. (ALNY) Bitcoin Incognito (XBI) Bristol-Myers Squibb Co (BMY) Cytokinetics Inc. (CYTK) Agios Pharmaceuticals, Inc. (AGIO) Blueprint Medicines Corporation (BPMC)
Top topics mentioned In the posts about BridgeBio Pharma, Inc. Common Stock in the last XX hours
stocks healthcare, alnylam pharmaceuticals inc, $ntla, $pfe, investment, $alny, stocks technology, $xbi, stocks consumer cyclical, stocks financial services, $vrna, stocks consumer defensive, $bmy, $cytk, stocks, $agio, dough, $abvx, $bpmc, $insm, $adea, $krtx, $myok, $mdgl, $axsm, hims hers, $prme, stocks industrials, stocks bitcoin treasuries, superrare, $bmrn, $alks, bloomberg, $bbc, $slb, $smtc, $mbly, cvs, stocks communication services, $vik, walt disney, $dis, $mtsr, $adur, stocks utilities, $aee, $aep, $mnst, $wrb, $asmb, $atmu, $atro, $aca, $aldx, $anab, $anip, $apps, dawn protocol, $abbv, nov inc, stocks energy, $nov, $akro, $ucb, neurocrine biosciences inc, $nbix, $glto, $gns, $cosm, genius group, coins base ecosystem, $xene, $imvt, hooked protocol, coins bsc, coins ai, coins gaming, $uuuu, cipher mining, $rgti, $elan, $nvda, $sats, $pl, $awi, bath body works inc, $bbwi, $azul, coins defi, $azek, $azta, stocks bitcoin miners, $apa, $ptgx, $nktr, $cldx, $iwm, $ruo, $wrld, $hlne
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@PersimmonTI What the remaining upside on $BBIO I have a hard time seeing a takeout narrative and the downside risk on the clinical side seems larger than the continued commercial improvement Obviously its up and to the right so what do i know"
X Link @Surfacetrawler 2025-10-14T22:50Z XX followers, XXX engagements
"Either via calls or common or both I am long the following - $ALNY $KYMR $INDV $BBIO $ABVX and $RYTM"
X Link @MacroSkokie 2025-10-14T16:10Z 1363 followers, XXX engagements
"And lets remember Intellias Class I/II would literally be off this graph Comparing $ALNY to $NTLA at 12m is like comparing prime Lebron James to Bronny. Heres the best part: XXXX% of Alnylam patients were Class I/II and they still had worsening of XX% on average at XX months. Intellias Class I/II 🟰 XXXX (3% improvement) And Intellia had one Class X who was variant and baseline 19600+ (the other companies had 8500 max). They died at Day XXX so its likely the XXXX wouldve been even better without them"
X Link @GeneInvesting 2025-10-14T15:03Z 14.5K followers, 4338 engagements
"Notable all-time/52-week highs and lows this AM: High: $BLK (post EPS) $FE $BBIO $IRON Low: $KYVO $OC $MAN $TRGP $AVY"
X Link @lonjuricic 2025-10-14T13:47Z XX followers, XXX engagements